GeneDx Holdings Corp. (WGS)

Last Closing Price: 52.21 (2026-06-05)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

GeneDx Holdings Corp. (WGS) had Net Income of $-63.32M for the most recently reported fiscal quarter, ending 2026-03-31.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
$102.25M
Net Income
$-63.32M
$34.04M
$68.21M
$159.72M
$-57.47M
$-4.95M
$-62.42M
$-62.42M
$-63.32M
$-63.32M
$-63.32M
$-63.32M
$-57.47M
$-50.66M
29.34M
29.34M
$-2.16
$-2.16
Balance Sheet Financials
$270.63M
$50.12M
$235.67M
$506.30M
$87.64M
$96.73M
$164.54M
$252.18M
$254.12M
$107.51M
$254.12M
29.67M
Cash Flow Statement Financials
$-32.41M
$-17.25M
$38.59M
$105.99M
$94.92M
$-11.07M
$9.00M
--
--
Fundamental Metrics & Ratios
3.09
--
--
0.28
0.38
66.71%
-56.20%
-56.20%
--
-61.04%
-61.92%
$-38.86M
--
--
--
0.20
2.78
1.33
67.71
-24.92%
-58.89%
-12.51%
-18.05%
$8.57
$-1.32
$-1.10